SEC Form 4 · accession 0001209191-17-009898
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maky Zanganeh
Director
Period of report
Feb 9, 2017
Accepted (ET)
Feb 13, 2017 · 1:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.55 | Feb 9, 2017 | A | 45,000 | A | Mar 9, 2017 | Feb 9, 2027 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1The shares subject to the option will vest in equal monthly installments over three years commencing on the date of grant subject to the Reporting Person's continued service to the Company.